|
Structural Bioinformatics Inc. (SBI), founded in 1996 in San Diego, CA, and its wholly owned subsidiary, SBI Advanced Technologies A/S, a Danish corporation founded in February 1998, provide unique, innovative I.T. solutions unifying genomics and combinatorial chemistry through a proprietary protein structure platform to accelerate drug discovery within the existing research infrastructure of the pharmaceutical industry. A portion of the company's core technology was originally developed and validated at ImmunoPharmaceutics, Inc., by a technical group that includes the scientific founders of SBI. This technology was successfully used for the generation of endothelin antagonists, fibroblast growth factor antagonists, TNF antagonists, and others now in various stages of development through Phase IIB clinical trials.
Activity:
- Informatics
- Other Industry Services
Product / Technology type(s) covered:
- Bio
- Proteins
- Technology
Therapeutic targets:
- Genetics
|
|
Company Contact
|
Structural Bioinformatics, Inc.
United States of America
Phone:
FAX:
Website: www.strubix.com
|
|